Multiple platforms are utilized for OA1 expression, each offering distinct advantages:
Ligand Affinity: Binds octopamine with a dissociation constant (K<sub>d</sub>) of 84.9 ± 17.4 nM in Lymnaea CNS membranes .
Receptor Specificity: Resembles insect OA<sub>2</sub> receptors rather than other molluscan subtypes .
Antagonists: Phentolamine, demethylchlordimeform (DCDM), and NC-7 block OA-induced responses .
OA application hyperpolarizes buccal B2 neurons (amplitude: 5–15 mV), reversible by OA antagonists .
Modulates feeding circuitry by synchronizing with rhythmic activity in buccal ganglia .
Feeding Behavior: OA1 activation primes the buccal central pattern generator to initiate feeding motor programs .
Memory Modulation: Lower endogenous OA levels correlate with enhanced long-term memory (LTM) formation in operant conditioning paradigms .
| Species | K<sub>d</sub> (nM) | B<sub>max</sub> (fmol/g tissue) |
|---|---|---|
| Lymnaea stagnalis | 84.9 ± 17.4 | 3803 ± 515 |
| Helix pomatia | 33.7 ± 5.95 | 1678 ± 179 |
Table: Comparative ligand-binding parameters between molluscan species .
Current research gaps include elucidating OA1’s role in insulin-like peptide signaling and its interaction with monoaminergic pathways in memory consolidation. Structural resolution via cryo-EM could enhance targeted drug design for neurobehavioral disorders.
Lymnaea stagnalis Octopamine receptor 1 is a G-protein coupled receptor found in the central nervous system of the great pond snail (Helix stagnalis). This receptor binds the neurotransmitter octopamine and plays a significant role in the neurophysiology of the snail's nervous system. The full-length receptor consists of 638 amino acids with specific structural domains that enable its function in signal transduction pathways .
The receptor is part of an octopaminergic system within the snail's CNS, where octopamine functions as a neurotransmitter and neuromodulator. This system is particularly important in the buccal ganglia of Lymnaea stagnalis, where octopamine plays a major role in regulating feeding-related behaviors .
The Lymnaea stagnalis Octopamine receptor 1 is a full-length protein of 638 amino acids. Its amino acid sequence is:
MSRDIFMKRLRLHLLFDEVAMVTHIVGDVLSSVLLCAVVLLVLVGNTLVVAAVATSRKLR TVTNVFIVNLACADLLLGVLVLPFSAVNEIKDVWIFGHVWCQVWLAVDVWLCTASILNLC CISLDRYLAITRPIRYPGLMSAKRAKTLVAGVWLFSFVICCPPLIGWNDGGDGIMDYNGT TATPIPVTTTQTPVTGRDDVLCDNGFNYSTNSNMNTTCTYSGDSSLSTTCELTNSRGYRI YAALGSFFIPMLVMVFFYLQIYRAAVKTISAYAKGELKTKYSVRENGSKTNSVTLRIHRG GRGPSTGSSVYRHGSTYGGSAAGAATREGCGDKDAAGGRRFGRQEMDSHLPVRKCRSSDA SLVTLTGLKCEIIDNGNAKHGPISELIKGRGKSFFWRKEKKRSVGGERESFENSTRNGRS TRAKLCGGRCLAIETDICSSGECSPRTKRIKEHARATQHNSLPVTPSLSSQNEETDAVFV RGTSNSEYKPRRSRLSAHKPGHAMRLHMQKFNREKKAAKTLAIIVGAFIMCWMPFFTIYL VGAFCENCISPIVFSVAFWLGYCNSAMNPCVYALFSRDFRFAFRKLLTCSCKAWSKNRSF RPQTSDVPAIQLHCATQDDAKSSSDIGPTASGGNGGYT
The protein contains multiple transmembrane domains characteristic of G-protein coupled receptors, which enable it to span the cell membrane and transduce signals from the extracellular environment to intracellular signaling pathways.
Octopamine shows an inhomogeneous distribution in the central nervous system of Lymnaea stagnalis. HPLC measurements reveal that:
The buccal ganglia contain the highest concentration of octopamine at 18.8 pmol mg⁻¹
The pedal ganglia have intermediate levels at 9.2 pmol mg⁻¹
The cerebral ganglia contain 4.9 pmol mg⁻¹
No detectable amount of octopamine is found in the visceroparietal complex
This distribution pattern is similar to that observed in Helix pomatia (terrestrial snail), which shows buccal ganglia concentrations of 12.6 pmol mg⁻¹, pedal ganglia at 4.93 pmol mg⁻¹, and cerebral ganglia at 4.46 pmol mg⁻¹ . The higher concentration in buccal ganglia correlates with octopamine's important role in feeding-related behaviors.
The recombinant full-length Lymnaea stagnalis Octopamine receptor 1 protein is primarily expressed in Escherichia coli (E. coli) expression systems. For research applications, the protein is typically produced with an N-terminal His tag to facilitate purification and detection . The recombinant protein spans the full length (amino acids 1-638) of the native receptor and is usually supplied as a lyophilized powder for experimental use .
The expression in bacterial systems like E. coli provides advantages for large-scale production of the protein for biochemical and structural studies, though it may lack some post-translational modifications present in the native receptor.
The signaling pathways associated with Lymnaea stagnalis Octopamine receptor 1 involve adenylyl cyclase-dependent mechanisms, similar to octopamine responses in insects . Experimental evidence suggests that:
In the B1 motoneuron, octopamine activation leads to depolarization through a cAMP-dependent pathway
This pathway is enhanced by IBMX (phosphodiesterase inhibitor), which increases cAMP levels
Forskolin (a direct adenylyl cyclase activator) mimics the octopamine response
The membrane-permeable cAMP analog 8-bromo-cAMP also depolarizes the B1 motoneuron
G-protein antagonist GDP-β-S blocks the response, confirming G-protein coupling
These observations support that Lymnaea stagnalis Octopamine receptor 1 couples to Gs proteins, activating adenylyl cyclase to increase cAMP levels, which subsequently modulates neuronal excitability through downstream effectors.
Electrophysiological studies reveal different responses to octopamine across various identified neurons in the Lymnaea stagnalis CNS:
| Neuron | Response to Octopamine | Threshold | Signaling Pathway |
|---|---|---|---|
| B1 | Depolarization | 5 μM | cAMP-dependent |
| B2 | Hyperpolarization | 5 μM | cAMP-independent |
| B3 | Hyperpolarization | 0.5 μM | cAMP-independent |
The B1 motoneuron depolarization response is enhanced by preincubation with IBMX (10 μM) and can be mimicked by direct cyclase activator forskolin (50 μM) or by 8-bromo-cAMP (2 mM) .
The hyperpolarization responses in B2 and B3 neurons operate through different mechanisms, as they are not affected by modulators of the cAMP pathway . The B3 neuron shows a particularly high sensitivity to octopamine with a threshold concentration approximately 10 times lower than the other neurons.
These differential responses suggest the presence of multiple octopamine receptor subtypes or different coupling mechanisms within the Lymnaea stagnalis nervous system.
The pharmacological properties of the Lymnaea stagnalis Octopamine receptor have been characterized through binding and functional studies. Interestingly, despite being from Lymnaea stagnalis, the receptor's pharmacological profile more closely resembles insect OA2 receptors rather than the cloned Lymnaea OA receptor .
Specific OA-ergic agents that selectively inhibit octopamine responses include:
Among dopamine antagonists:
Ergotamine reversibly inhibits octopamine responses
The binding characteristics of the receptor have been determined through Scatchard analysis of ligand binding data:
In Lymnaea: Kd = 84.9 ± 17.4 nM and Bmax = 3803 ± 515 fmol g⁻¹ tissue
In Helix: Kd = 33.7 ± 5.95 nM and Bmax = 1678 ± 179 fmol g⁻¹ tissue
These binding parameters suggest a single receptor site with moderate affinity for octopamine.
Octopamine uptake in Lymnaea stagnalis presents a complex system with multiple components. The synaptosomal fraction from Lymnaea ganglia exhibits a biphasic uptake mechanism with:
A high-affinity component: Km1 = 4.07 ± 0.51 μM, Vmax1 = 0.56 ± 0.11 pmol mg⁻¹ per 20 min
A low-affinity component: Km2 = 47.6 ± 5.2 μM, Vmax2 = 4.2 ± 0.27 pmol mg⁻¹ per 20 min
This dual-component uptake system complicates the study of octopamine neurotransmission as it suggests multiple mechanisms for regulating extracellular octopamine levels.
Additionally, pharmacological studies of octopamine receptors face challenges such as:
The need for extremely high concentrations (1-3 mM) of cyclase blockers SQ 22536 and Rp-cAMPS to see effects
The possibility that the tissue sheath or glial cells prevent drugs from reaching the neurons
Differential responses across neuronal types that require cell-specific approaches
These challenges necessitate careful experimental design when studying octopamine signaling in the Lymnaea stagnalis nervous system.
Proper storage and reconstitution of recombinant Lymnaea stagnalis Octopamine receptor 1 is crucial for maintaining its functional integrity in experimental settings. The recommended protocol is:
Storage conditions:
Store at -20°C/-80°C upon receipt
Aliquoting is necessary for multiple use to avoid repeated freeze-thaw cycles
Reconstitution protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add 5-50% glycerol (final concentration) and aliquot for long-term storage
Storage buffer composition:
The reconstituted protein should have a purity greater than 90% as determined by SDS-PAGE. Repeated freezing and thawing is not recommended as it may compromise protein integrity and functionality.
The Lymnaea stagnalis Octopamine receptor 1 belongs to the larger family of G-protein coupled receptors that bind monoamine neurotransmitters. Pharmacological characterization suggests that the Lymnaea octopamine receptor more closely resembles insect OA2 receptors than the cloned Lymnaea OA receptor , which indicates a complex evolutionary history.
This resemblance to insect receptors rather than other molluscan receptors raises interesting questions about:
Convergent evolution of receptor properties
Ancestral receptor types that diverged differently across invertebrate lineages
Functional constraints that may have shaped receptor pharmacology similarly across distant taxa
Comparative studies of octopamine receptors across invertebrate phyla could yield valuable insights into the evolution of monoaminergic signaling systems and their roles in behavior and physiology. The conservation of specific binding domains and signal transduction mechanisms across species could reveal fundamental principles of GPCR function that have been maintained through evolutionary time.
Immunocytochemical labeling has been successfully employed to visualize octopamine-containing neurons in the Lymnaea stagnalis central nervous system. This technique has revealed:
The presence of OA-immunoreactive neurons and fibers in the buccal, cerebral, and pedal ganglia
The absence of OA-immunoreactive elements in the visceroparietal complex, consistent with the HPLC findings
The distribution pattern of octopaminergic neurons correlates with their functional importance in feeding and locomotion
The immunocytochemical approach typically involves:
Fixation of the isolated CNS
Sectioning the tissue
Incubation with primary antibodies against octopamine
Visualization using fluorescent or enzymatic secondary detection methods
Microscopic analysis to map the distribution of labeled cells and processes
This technique complements biochemical and electrophysiological approaches by providing spatial information about octopamine-containing elements in the nervous system.
Electrophysiological characterization of Lymnaea stagnalis Octopamine receptor function involves several specialized techniques:
Preparation:
Recording setup:
Drug application methods:
Response characterization:
Measurement of membrane potential changes
Determination of response thresholds
Characterization of dose-response relationships
Analysis of response kinetics
These methods allow for detailed functional characterization of octopamine receptors in their native neuronal environment, providing insights into their physiological roles and signaling mechanisms.
Lymnaea stagnalis offers significant advantages as a model for translational neuroscience research, particularly in the study of monoaminergic signaling systems:
Well-characterized nervous system:
Evolutionary insights:
Learning and memory models:
Practical advantages:
Relatively simple nervous system compared to vertebrates
Large neurons facilitate electrophysiological and molecular studies
Well-established techniques for studying receptor function in native context
These characteristics make Lymnaea stagnalis a valuable model for understanding the fundamental mechanisms of neuromodulation by biogenic amines, with potential implications for human neurological and psychiatric conditions involving monoaminergic signaling.
Future research on Lymnaea stagnalis Octopamine receptor 1 will likely leverage advanced techniques to elucidate structure-function relationships:
Cryo-electron microscopy:
Determination of high-resolution receptor structure
Visualization of ligand binding sites
Understanding conformational changes during activation
CRISPR-Cas9 genome editing:
Generation of receptor mutants in Lymnaea stagnalis
Study of structure-function relationships in vivo
Analysis of behavioral consequences of receptor modifications
Optogenetic approaches:
Light-controlled activation of octopaminergic neurons
Temporal precision in studying receptor-mediated responses
Integration of receptor function into circuit-level understanding
Advanced heterologous expression systems:
Expression in mammalian cell lines for functional studies
Development of stable cell lines for high-throughput screening
Co-expression with various G proteins to study coupling specificity
These approaches will provide deeper insights into how the structural features of Lymnaea stagnalis Octopamine receptor 1 determine its functional properties and contribute to the physiology of the nervous system.
Comparative studies of octopamine receptors across species offer a unique window into GPCR evolution:
Phylogenetic analysis:
Reconstruction of evolutionary relationships between octopamine, tyramine, dopamine, and adrenergic receptors
Identification of ancestral receptor types and their divergence patterns
Understanding of how receptor specificities evolved across invertebrate lineages
Structural comparisons:
Identification of conserved domains critical for ligand binding and G-protein coupling
Understanding of how structural changes relate to functional diversity
Recognition of convergent evolution in receptor properties
Functional conservation:
Comparison of signaling pathways across species
Identification of conserved cellular responses to receptor activation
Understanding of how receptor function relates to behavioral outputs
Ecological and behavioral context:
Correlation of receptor properties with ecological niches
Understanding how environmental pressures shaped receptor evolution
Insights into the adaptive significance of octopamine signaling
These comparative approaches will help establish Lymnaea stagnalis Octopamine receptor 1 within the broader context of GPCR evolution and may reveal fundamental principles governing the structure, function, and regulation of this important receptor family.
Current research on Lymnaea stagnalis Octopamine receptor 1 has established its basic molecular properties, pharmacological profile, and role in neuronal signaling. Key findings include:
The receptor consists of 638 amino acids and can be expressed as a recombinant protein with an N-terminal His tag in E. coli systems
Octopamine distribution in the Lymnaea CNS is highest in the buccal ganglia, with significant levels also in pedal and cerebral ganglia
Different neurons exhibit distinct responses to octopamine:
The pharmacological profile of the receptor more closely resembles insect OA2 receptors than other cloned Lymnaea receptors
The receptor functions in a complex octopaminergic system that likely plays important roles in feeding and other behaviors
Despite these advances, many aspects of the receptor's structure-function relationships, its role in neural circuits, and its contribution to behavior remain to be fully elucidated. The availability of recombinant protein and established experimental techniques position the field for significant future discoveries.